174 results
DEFA14A
FRTX
Fresh Tracks Therapeutics, Inc.
13 Nov 23
Additional proxy soliciting materials
8:48am
primarily due to severance expense, partially offset by $0.5 million in lower legal and compliance fees.
The Company reported net income of $2.1
8-K
EX-99.1
FRTX
Fresh Tracks Therapeutics, Inc.
13 Nov 23
Fresh Tracks Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
8:33am
primarily due to severance expense, partially offset by $0.5 million in lower legal and compliance fees.
The Company reported net income of $2.1
8-K
EX-99.1
ydsa6
10 May 23
Fresh Tracks Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:04pm
8-K
EX-99.1
9c5ky2j6 ayb
30 Mar 23
Fresh Tracks Therapeutics Reports Fourth Quarter and Full Year 2022
4:03pm
8-K
EX-99.1
kwl0m 93y9o3yjjq692
10 Nov 22
Fresh Tracks Therapeutics Reports Third Quarter 2022
4:10pm
8-K
EX-99.1
0f8vgmx1rj lrapaz
11 Aug 22
Brickell Biotech Reports Second Quarter 2022
4:09pm
8-K
EX-10.1
vozzchrezx
17 May 22
Departure of Directors or Certain Officers
4:14pm
8-K
EX-99.1
8oj6 gw40ns2rev
12 May 22
Brickell Biotech Reports First Quarter 2022
4:05pm
8-K
EX-10.1
rb36pkwla2sm wvfz7pk
3 May 22
Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals
4:08pm